This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, S. K. Articles by Friend, D. S. Search for Related Content PubMed PubMed Citation Articles by Huang, S. K. Articles by Friend, D. S.

American Journal of Pathology, Vol 143, 10-14, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene

SK Huang, FJ Martin, G Jay, J Vogel, D Papahadjopoulos and DS Friend
Cancer Research Institute, University of California, San Francisco.

Transgenic mice bearing the HIV tat gene develop dermal lesions resembling a common malignant tumor in AIDS, Kaposi's sarcoma (KS). To evaluate the permeability characteristics of these lesions and the therapeutic potential of drug-carrying liposomes, we have studied the localization of sterically stabilized liposomes, which show long circulation time in blood and increased accumulation in tumors. Liposomes encapsulating colloidal gold were injected intravenously into transgenic mice bearing KS lesions, and tissues were processed 24 hours later for both electron microscopy and for light microscopy with silver enhancement. Liposomes and silver marker were detected predominantly in the dermis surrounding the early and mature KS lesions, which were characterized by a proliferation of fibroblast-like spindle cells and abnormal blood vessels close to the epidermis. The silver-enhanced gold marker often surrounded vascular channels and scattered erythrocytes. As determined by electron microscopy, some spindle cells and macrophages had ingested intact liposomes. Transendothelial transport of liposomes was observed both through open channels between endothelial cells and also through endothelial cells lining intact vessels. Both extravasation and transcytosis of liposomes through irregular endothelium were much higher in KS lesions than in the adjacent normal skin. The high accumulation of sterically stabilized liposomes in KS lesions and their intracellular uptake by some spindle cells enhances their potential as carriers of chemotherapeutic agents against this neoplasm.

This article has been cited by other articles:

				Y. Fujisaka, A. Horiike, T. Shimizu, N. Yamamoto, Y. Yamada, and T. Tamura Phase 1 Clinical Study of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Solid Tumors Jpn. J. Clin. Oncol., December 1, 2006; 36(12): 768 - 774. [Abstract] [Full Text] [PDF]

				S. Sofou, J. L. Thomas, H.-y. Lin, M. R. McDevitt, D. A. Scheinberg, and G. Sgouros Engineered Liposomes for Potential {alpha}-Particle Therapy of Metastatic Cancer J. Nucl. Med., February 1, 2004; 45(2): 253 - 260. [Abstract] [Full Text] [PDF]

				V. E. Kouloulias, C. E. Dardoufas, J. R. Kouvaris, C. S. Gennatas, A. K. Polyzos, H. J. Gogas, P. H. Sandilos, N. K. Uzunoglu, E. G. Malas, and L. J. Vlahos Liposomal Doxorubicin in Conjunction with Reirradiation and Local Hyperthermia Treatment in Recurrent Breast Cancer: A Phase I/II Trial Clin. Cancer Res., February 1, 2002; 8(2): 374 - 382. [Abstract] [Full Text] [PDF]

				R. Krishna, M. S. Webb, G. St. Onge, and L. D. Mayer Liposomal and Nonliposomal Drug Pharmacokinetics after Administration of Liposome-Encapsulated Vincristine and Their Contribution to Drug Tissue Distribution Properties J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1206 - 1212. [Abstract] [Full Text] [PDF]

				H. Sakai, H. Horinouchi, K. Tomiyama, E. Ikeda, S. Takeoka, K. Kobayashi, and E. Tsuchida Hemoglobin-Vesicles as Oxygen Carriers : Influence on Phagocytic Activity and Histopathological Changes in Reticuloendothelial System Am. J. Pathol., September 1, 2001; 159(3): 1079 - 1088. [Abstract] [Full Text] [PDF]

				D. Emfietzoglou, K. Kostarelos, and G. Sgouros An Analytic Dosimetry Study for the Use of Radionuclide-Liposome Conjugates in Internal Radiotherapy J. Nucl. Med., March 1, 2001; 42(3): 499 - 504. [Abstract] [Full Text]

				D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors Pharmacol. Rev., December 1, 1999; 51(4): 691 - 744. [Abstract] [Full Text] [PDF]

				M. I. Koukourakis, S. Koukouraki, A. Giatromanolaki, S. C. Archimandritis, J. Skarlatos, K. Beroukas, J. G. Bizakis, G. Retalis, N. Karkavitsas, and E. S. Helidonis Liposomal Doxorubicin and Conventionally Fractionated Radiotherapy in the Treatment of Locally Advanced Non-Small-Cell Lung Cancer and Head and Neck Cancer J. Clin. Oncol., November 1, 1999; 17(11): 3512 - 3521. [Abstract] [Full Text] [PDF]

				R.-L. Hong, C.-J. Huang, Y.-L. Tseng, V. F. Pang, S.-T. Chen, J.-J. Liu, and F.-H. Chang Direct Comparison of Liposomal Doxorubicin with or without Polyethylene Glycol Coating in C-26 Tumor-bearing Mice: Is Surface Coating with Polyethylene Glycol Beneficial? Clin. Cancer Res., November 1, 1999; 5(11): 3645 - 3652. [Abstract] [Full Text] [PDF]

				D. Lasic and D Papahadjopoulos Liposomes revisited Science, March 3, 1995; 267(5202): 1275 - 1276. [PDF]